KBC Group NV »

Longboard Pharmaceuticals In shares owned by KBC Group NV

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-09-30 $65k 2.0k 33.27

More positions owned by KBC Group NV

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
salesforce (CRM)
Broadcom (AVGO)
Applied Materials (AMAT)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Linde SHS (LIN)

View all positions for KBC Group NV

Top funds holding Longboard Pharmaceuticals In

Farallon Capital Management
T. Rowe Price Associates
BlackRock
Cormorant Asset Management
BlackRock
Viking Global Investors
Vanguard Group
Woodline Partners
Pictet Asset Management Holding SA
Jennison Associates
Siren
State Street Corporation
Geode Capital Management
Driehaus Capital Management
Parkman Healthcare Partners

View all funds holding Longboard Pharmaceuticals In